EUQPPV Archives - Arriello

Globally experienced Commercial Director joins Arriello

Adam Sherlock has been appointed as Commercial Director at Arriello to spearhead growth with the commercial development team. Adam brings his extensive industry knowledge and insight to team yellow following recent successful board level positions at life sciences providers Kinapse and Product Life.

Arriello now offering Clinical Trials services.

Arriello is now offering a wide range of Clinical Trials services. The outsourcing of clinical activities and guidance is now a widely accepted, approved and in-demand practice.

Arriello at the World Drug Safety Congress Americas 2019

Arriello attends and steps in on request to host 2 round table discussions on Russia and Eurasia PV requirements at the World Drug Safety Congress Americas 2019 in Philadelphia from the 15th to 17th of April in Philadelphia.

Arriello attends ISoP Intelligent Automation in Pharmacovigilance 2018

The 3rd and 4th of December saw Arriello founders Alan White and Anna Lukyanova, and Marketing Director Rob Curtis, at the 2nd ISoP Intelligent Automation in Pharmacovigilance seminar, hosted by Biogen in Cambridge, Boston.

Arriello leads roundtable discussion at Proventa Strategy Meeting 2018

Arriello leads a roundtable discussion at Proventa Strategy Meeting 2018 in Boston discussing the EU landscape, Brexit and the implications and changes for both.

Brexit means Brexit – The role of the EUQPPV and EU Regulatory Submissions

It was announced last week by the EMA that there would be significant and tangible changes and impact from the UK decision to leave the European Union.

Faster, better, smarter is just a click away…

If you’re looking for real bottom line results, find out how we’ve consistently met that challenge and exceeded expectations.